Acute coronary syndrome
356 results
1 - 100
Acute coronary syndrome - Essentials
- Follow-up management
- Symptoms and clinical diagnosis
- References
- Diagnostic investigations
- Initial management
- Treatment of UAP and NSTEMI
- Treatment of STEMI
- Arrhythmias associated with myocardial infarction
- Right ventricular infarction
- Acute coronary syndrome triggered by other factors
- Inpatient treatment
- Fondaparinux for acute coronary syndromes
- Diagnostic classification of acute coronary syndromes - Image
- Statins for acute coronary syndrome
Statins for acute coronary syndrome- Hyperbaric oxygen therapy for acute coronary syndrome
Presence of risk factors doesn't predict acute coronary syndrome- Clinical decision helpful in diagnosis of acute coronary syndrome in primary care
- Low molecular weight heparins for acute coronary syndromes
- Heparin versus placebo for non‐ST elevation acute coronary syndromes
- Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes
- Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome
- Patients with non-ST-elevation acute coronary syndromes do not need immediate intervention
- Escitalopram reduces risk of adverse cardiac events in adults with depression and acute coronary syndrome
- Factor Xa inhibitors for acute coronary syndromes: Cochrane systematic review
- Direct thrombin inhibitors and factor Xa inhibitors for acute coronary syndromes: a network meta‐analysis
- Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes: Cochrane systematic review
- For treatment of acute coronary syndrome, prasugrel is better than ticagrelor at preventing recurrent MIs at 1 year
- PSK9 inhibitor alirocumab reduces nonfatal MI in patients after acute coronary syndrome, but at high cost (ODYSSEY OUTCOMES)
- Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes: Cochrane systematic review
- Early CT angiography for suspected acute coronary syndrome reduces further ischemic testing; no effect on long-term clinical outcomes
- Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes: Cochrane systematic review
- After 1 month of DAPT after PCI for acute coronary syndromes, ticagrelor monotherapy results in similar outcomes with less bleeding than ticagrelor plus aspirin